Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic Covid-19 infection in Sweden: A nationwide cohort study

Summary: Background: The effectiveness of heterologous prime-boost Coronavirus disease 2019 (Covid-19) vaccination is currently unknown. Methods: From individuals vaccinated with two doses against Covid-19 in Sweden until July 5, 2021 (N=3,445,061), we formed a study cohort including 94,569 individ...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Peter Nordström, Marcel Ballin, Anna Nordström
Format: article
Langue:EN
Publié: Elsevier 2021
Sujets:
Accès en ligne:https://doaj.org/article/d2b2b1b5117f49ecb1e56dfeb11de756
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!